Difficulty: Medium
Average Score: 74%
Practice
Caution should be taken regarding clients who have been prescribed guaifenesin in the presence of asthma diagnosis because
Correct answer
A
Rationale
In the context of pharmacology and asthma management, it is important to understand the potential effects of medications on respiratory function. Guaifenesin, commonly used as an expectorant to help loosen mucus in the airways, can pose a risk to clients with asthma due to its potential to cause bronchospasm, which is the constriction of the airway muscles leading to difficulty in breathing.
Option A, "guaifenesin can cause bronchospasm," is the correct answer because it directly addresses the concern of exacerbating asthma symptoms by inducing bronchospasm. This highlights the need for caution when prescribing guaifenesin to individuals with asthma.
Options B and C are incorrect because they do not accurately reflect the specific risk associated with guaifenesin use in asthma. Bronchoconstriction (option B) and decreased diameter of bronchial lumina (option C) are related to airway narrowing but do not directly address the issue of bronchospasm induced by guaifenesin in asthma patients.
Educationally, understanding the potential adverse effects of medications in specific patient populations, such as those with asthma, is crucial for safe and effective pharmacological management. This rationale emphasizes the importance of considering individual patient factors, like underlying conditions, when making prescribing decisions to ensure patient safety and optimal outcomes.
Option A, "guaifenesin can cause bronchospasm," is the correct answer because it directly addresses the concern of exacerbating asthma symptoms by inducing bronchospasm. This highlights the need for caution when prescribing guaifenesin to individuals with asthma.
Options B and C are incorrect because they do not accurately reflect the specific risk associated with guaifenesin use in asthma. Bronchoconstriction (option B) and decreased diameter of bronchial lumina (option C) are related to airway narrowing but do not directly address the issue of bronchospasm induced by guaifenesin in asthma patients.
Educationally, understanding the potential adverse effects of medications in specific patient populations, such as those with asthma, is crucial for safe and effective pharmacological management. This rationale emphasizes the importance of considering individual patient factors, like underlying conditions, when making prescribing decisions to ensure patient safety and optimal outcomes.